Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both

Journal of Pediatric Gastroenterology and Nutrition

Volumn 47, Issue 3, 2008, Pages 283-287

  Dezsodfi A ^a   Szebeni, B ^a   Hermann, C ^b   Kapitany A ^b   Veres, G ^a   Sipka, S ^c   Korner A ^a   Madacsy L ^a   Korponay Szabo I ^d   Rajczy, K ^e   Arato A ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b St Rókus Hospital   (Hungary)

^c Third Dept of Internal Medicine   (Japan)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e Hungarian National Blood Transfusion Service   (Hungary)

Author keywords

Celiac disease; HLA antigens; Toll like receptors; Type 1 diabetes mellitus

Indexed keywords

CD14 ANTIGEN; DNA; HLA DQ ANTIGEN; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADOLESCENT; ALLELE; ARTICLE; CELIAC DISEASE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HLA SYSTEM; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; CHILD; COMORBIDITY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METHODOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ANTIGENS, CD14; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 58149235445     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31816de885     Document Type: Article

References (44)

1. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81.
2. Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003;362:30-7.
3. Arató A, Körner A, Veres G, et al. Frequency of coeliac disease in Hungarian children with type 1 diabetes mellitus. Eur J Pediatr 2003;162:1-5.
4. Ludvigsson JF, Ludvigsson J, Ekbom A, et al. Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care 2006;29:2483-8.
5. van Aautreve JE, Weets I, Gulbis B, et al. The rare HLA-DQA1*-3- DQB1* 02 haplotype confers susceptibility to type 1 diabetes in whites and is preferentially associated with early clinical disease onset in male subjects. Hum Immunol 2004;65:729-36.
6. Forsberg G, Fahlgren A, Horstedt P, et al. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol 2004;99:894-904.
7. Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-3.
8. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-45.
9. Inohara N, Ogura Y, Chen FF, et al. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 2001;276: 2551-4.
10. Inohara N, Ogura Y, Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol 2002;5:76-80.
11. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.
12. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276:4812-8.
13. Baldini M, Lohman IC, Halonen M, et al. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999;20:976-83.
14. Klein W, Tromm A, Griga T, et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 2002;37:189-91.
15. Obana N, Takahashi S, Kinouchi Y, et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol 2002;37:699-704.
16. -260 T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999;99:3218-20.
17. Jarvelainen HA, Orpana A, PerolaM, etal. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001;33:1148-53.
18. KoppelmanGH, ReijmerinkNE, Colin StineO, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 2001;163:965-9.
19. terSteege J, Buurman W, Arends JW, et al. Presence of inducible nitric oxide synthase, nitrotyrosine, CD68 and CD14 in the small intestine in celiac disease. Lab Invest 1997;77:29-36.
20. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91.
21. Arató A, Körner A, Veres G, et al. Frequency of coeliac disease in Hungarian children with type 1 diabetes mellitus. Eur J Pediatr 2003;162:1-5.
22. Walker-Smith JA, Guandalini S, Schmitz J, et al. Revised criteria for diagnosis of coeliac disease: report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990;65:909-11.
23. Szebeni B, Szekeres R, Rusai K, et al. Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants. J Pediatr Gastroenterol Nutr 2006;42:27-31.
24. Lorenz E, Frees KL, Schwartz DA, et al. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques 2001;31:22-4.
25. Eng HL, Wang CH, Chen CH, et al. A CD14 promoter polymorphism is associated with CD14 expression and chlamydia-stimulated TNF alpha production. Genes Immun 2004;5:426-30.
26. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens 1992;39:225-35.
27. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996;4:407-14.
28. Klöting N, Klöting I, Jack RS. CD14 triggers autoimmune type 1 diabetes in the NOD mouse. Diabetologia 2004;47:151-2.
29. Devitt A, Moffatt OD, Raykundalia C, et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998;392: 505-9.
30. Schlegel RA, Krahling S, Callahan MK, et al. CD14 is a component of multiple recognition systems used by macrophages to phagocy-tose apoptotic lymphocytes. Cell Death Differ 1999;6:583-92.
31. Fadok VA, Warner ML, Bratton DL, et al. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol 1998;161:6250-7.
32. Moffatt OD, Devitt A, Bell ED, et al. Macrophage recognition of ICAM-3 on apoptotic leukocytes. J Immunol 1999;162:6800-10.
33. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-9.
34. Ronchetti A, Rovere P, Iezzi G, et al. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells and cytokines. J Immunol 1999;163:130-6.
35. Rey Nores JE, Bensussan A, Vita N, et al. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol 1999;29:265-76.
36. O'Neill LAJ, Dinarello CA. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defence. Immunol Today 2000;21:206-9.
37. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol 1997;53:1-11.
38. Koeleman BP, Lie BA, Undlien DE, et al. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun 2004;5:381-8.
39. Sumnik Z, Cinek O, Bratanic N, et al. Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB1*02- DQA1*05 and TNF -308A. Diabetes Care 2006;29: 858-63.
40. Saukkonen T, Savilahti E, Reijonen H, et al. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group. Diabet Med 1996;13:464-70.
41. Sumnik Z, Kolouskova S, Cinek O. HLA-DQA1*05-DQB1*0201 positivity predisposes to coeliac disease in Czech diabetic children. Acta Paediatr 2000;89:1426-30.
42. Contreas G, Valletta E, Ulmi D, et al. Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing. Acta Paediatr 2004;93:628-32.
43. Doolan A, Donaghue K, Fairchild J, et al. Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care 2005;28:806-9.
44. Bao F, Yu L, Babu S. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 1999;13:143-8.